Drug intelligence / Profile preview

acetaminophen + aspirin + caffeine

Development stage
Phase 4
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral
01

Overview

Acetaminophen + aspirin + caffeine is an oral fixed-dose combination analgesic used to treat mild to moderate pain such as tension headaches and migraine. It contains three active ingredients: - Acetaminophen (paracetamol), an analgesic and antipyretic that reduces pain and fever by acting on the central nervous system. - Aspirin (acetylsalicylic acid), a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes to reduce inflammation and pain. - Caffeine is a central nervous system stimulant that acts as an adenosine receptor antagonist; it enhances the analgesic effects of acetaminophen and aspirin while also helping relieve headache symptoms. This triple combination has been shown to be more effective than any of its individual components or dual combinations for acute headache relief. The product is available over-the-counter in many countries under various brand names. Chronic or excessive use can increase risks of hepatotoxicity (from acetaminophen), gastrointestinal bleeding (from aspirin), renal papillary necrosis with long-term high doses of both acetaminophen and aspirin together; caffeine may cause insomnia or palpitations in sensitive individuals[1][2][3][4].

Brand names
Excedrin Extra StrengthExcedrin MigraineBayer Migraine FormulaVanquishGoody's Extra StrengthGoody's Headache PowdersAnacin Advanced Headache FormulaArthritenBackaid IPFPamprin MaxBC MAX STRENGTH Fast Pain ReliefMelabon KNeuralgin Classic
Other names
acetaminophen-aspirin-caffeine drug combinationaspirin/paracetamol/caffeine combination
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)ADORA2B (Adenosine A2B receptor)ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)

Beyond the preview

Go deeper on acetaminophen + aspirin + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + aspirin + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call